TP53 and Miyoshi myopathy: Because of uncertainty about the optimal subsequent therapeutic strategy, WGTS analysis was performed and revealed a TP53 mutation as an additional high-risk feature and hyperhaploidy with numerous chromosomal losses, which is also associated with an unfavorable prognosis in MM [22].